Nutraveris

Category 'News'

Thursday, June 22, 2017

Gymnema sylvestre consumption improves biomarkers of metabolic syndrome.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The aim of this study was to evaluate the effect of Gymnema sylvestre consumption on metabolic syndrome, insulin secretion, and insulin sensitivity.

A randomized, double-blind, placebo-controlled clinical trial was carried out in 24 patients (without pharmacological treatment), 30-60 years old, with diagnosis of metabolic syndrome. Patients were randomly assigned to receive G. sylvestre or placebo twice daily in 300 mg capsules for a total of 600 mg/day for 12 weeks.

 

Gymnema sylvestre

 

After G. sylvestre administration, significant decreases in body weight (81.3 ± 10.6 kg vs. 77.9 ± 8.4 kg, p = 0.02), BMI (31.2 ± 2.5 kg/m² vs. 30.4 ± 2.2 kg/m², p = 0.02), and VLDL levels (0.45 ± 0.15 mmol/dL vs. 0.35 ± 0.15 mmol/dL, p = 0.05) were observed, without modifying the components of metabolic syndrome, insulin secretion, and insulin sensitivity.

 

In conclusion, Gymnema sylvestre administration decreased body weight, BMI, and VLDL levels in subjects with metabolic syndrome, without changes in insulin secretion and insulin sensitivity.

 

 

Zuñiga LY, González-Ortiz M, Martínez-Abundis E. Effect of Gymnema sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. J Med Food. 2017 May 1.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

 

Tuesday, June 20, 2017

Saffron versus Fluoxetine for postpartum depression.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

The aim of this 6-week, double-blind, randomized clinical trial was to compare safety and efficacy of saffron and fluoxetine in treatment of mild to moderate postpartum depression in women aged 18-45 years with mild to moderate postpartum depression. Participants received either a capsule of saffron (15mg capsule) or fluoxetine (20 mg capsule) twice daily for 6 weeks.

 

postpartum depression

 

There was no significant effect for time×treatment interaction on HDRS score [F (4.90, 292.50) = 1.04, p=0.37] between the 2 groups. 13 (40.60%) patients in the saffron group experienced complete response (≥50% reduction in HDRS score) compared with 16 (50%) in the fluoxetine group and the difference between the 2 groups was not significant in this regard (p=0.61). Frequency of adverse events was not significantly different between the treatment groups.

 

The results of this study may suggest that saffron is a safe alternative medication for improving depressive symptoms of postpartum depression.

 

 

Kashani L, Eslatmanesh S, Saedi N, Niroomand N, Ebrahimi M, Hosseinian M, Foroughifar T, Salimi S, Akhondzadeh S. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial. Pharmacopsychiatry. 2017 Mar;50(2):64-68.

 

This information has been sourced bNOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Friday, June 16, 2017

Dried plum increases osteoblast activity: an interest for osteoporosis?

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

Preclinical data has suggested that dried plum may affect bone heath.

In this study, the effects of dried plums on osteoblast activity and gene expression. 5 healthy women ingested 100 g of dried plum and plasma samples have been collected after 1 and 2h. Then, osteoblast cells were treated with these serum samples for 3 or 9 days.

 

Dried plum

 

Intracellular and extracellular alkaline phosphatase activities were increased after 3 or 0 days of treatment. Moreover, plasma samples increased the mRNA expression of bone markers RUNX2 and connexin 43, as mRNA expression of β-catenin.

The authors concluded that osteoblast activity and function are increased by dried plum ingestion, which may therefore have beneficial effects on bone health, especially in osteoporotic patients.

 

Delgado Cuenca P, Almaiman L, Schenk S, Kern M, Hooshmand S. Dried Plum Ingestion Increases the Osteoblastogenic Capacity of Human Serum. J Med Food. 2017 Apr 26.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Wednesday, June 14, 2017

Nutraveris at NutEvent, 14th – 15th June , Lille

NutrEvent 2017

 

NutrEvent is the European Business convention where Food, Nutrition an Health innovators converge.

Come and meet us on our booth:

 

Nutraveris at NutrEvent

 

 

For more informations: contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

 

Tuesday, June 13, 2017

Micronutrients effective in older adult disorders: bone, skeletal muscle, and cognitive function.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

The aim of this review was to summarize the state of the art regarding micronutrients in order to identify which of them might effectively improve health status in the areas typically impaired in older people: bone, skeletal muscle, and cognitive function.

The Italian Study Group on Healthy Aging by Nutraceuticals and Dietary Supplements performed this scoping review.

In literature, 12 relevant positive studies were founded.

Only 16 micronutrients resulted to have appropriate scientific evidences in terms of improving musculoskeletal health and/or cognitive function in older people: β-alanine, calcium, creatine, fluorides, leucine, magnesium, omega-3 fatty acids, potassium, vitamin B6, B9, B12, C, D, E, K2, and zinc.

Micronutrients effective in older adult disorders: bone, skeletal muscle, and cognitive function.

Effective daily doses of selected micronutrients that improve health status in the 3 areas (bone, skeletal muscle, and cognitive function), impaired in elderly.

This scoping review showed that selected micronutrients in adequate doses might have an ancillary role in musculoskeletal health and cognitive functions in older people.

Iolascon G, Gimigliano R, Bianco M, De Sire A, Moretti A, Giusti A, Malavolta N, Migliaccio S, Migliore A, Napoli N, Piscitelli P, Resmini G, Tarantino U, Gimigliano F. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review. J Nutr Health Aging. 2017;21(5):527-538.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87